Obesity-induced inflammation has been reported to disrupt BCRP function, particularly in the intestine, leading to compromised drug efflux, increased gut permeability, and altered cholesterol handling. Here, ABCG2 is linked to obesity due to melanocortin 4 receptor deficiency.